Premium Sermorelin for growth research
A growth hormone-releasing hormone (GHRH) analog used in research on growth hormone deficiency and age-related GH decline.
- GHRH analog
- Third-party tested
- Lyophilized peptide
SermorelinSermorelin is a 29-amino-acid fragment of endogenous GHRH, retaining the receptor-binding domain required to stimulate pituitary GH release. Research applications focus on the somatotropic axis — pulsatile GH secretion, IGF-1 response curves, and age-related attenuation of the growth hormone cascade.
- Strength
- 5mg
- Form
- Lyophilized research material
- Testing
- Third-party tested
- Documentation
- COA available on request
Keep lyophilized material sealed, protected from light, and handled with standard laboratory controls. Follow your institution’s SOPs for storage, reconstitution, labeling, and disposal.
No FDA-approved Sermorelin drug product exists for any indication. Sermorelin is not listed as an FDA-approved active ingredient and is sold in the United States only as a research chemical for in-vitro and laboratory study.
We display certificates — mass spec, HPLC purity — for all research-grade material. Use results to confirm identity, purity, and batch traceability. Certificate viewer coming soon.